Items where Author is "Caizergues, D"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Wagner, K R and De Luca, A and Caizergues, D and Dowling, J and Goemans, N and Gordish-Dressman, H and Grounds, M D and Kelly, M and Mayhew, A and McNally, E M and Zoetis, T and Lee, J and Turner, C and Wells, D J and Csimma, C and Straub, V (2019) A decade of optimizing drug development for rare neuromuscular disorders through TACT. Nature Reviews Drug Discovery, 19 (1-2).

Heslop, E and Csimma, C and Straub, V and McCall, J and Nagaraju, K and Wagner, K R and Caizergues, D and Korinthenberg, R and Flanigan, K M and Kaufmann, P and McNeil, E and Mendell, J and Hesterlee, S and Wells, D J (2015) The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. ORPHANET JOURNAL OF RARE DISEASES, 10 (49).

Wells, D J and Heslop, E and Csimma, C and Straub, V and McCall, J and Nagaraju, K and Wagner, K and Caizergues, D and Korinthenberg, R and Flanigan, K and Mendell, J and Kelly, M and Kaufmann, P and McNeil, E and Robertson, A and Johnston, L and Bushby, K (2015) THE TREAT-NMD ADVISORY COMMITTEE FOR THERAPEUTICS (TACT): AN INNOVATIVE DE-RISKING MODEL TO FOSTER ORPHAN DRUG DEVELOPMENT. Neuromuscular Disorders, 25. S271-S271.

This list was generated on Sat Dec 4 07:17:40 2021 GMT.